Development of shield-arms typed oligonucleotides for cancer therapy
Project/Area Number |
23790202
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Medical pharmacy
|
Research Institution | St. Marianna University School of Medicine |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 医療薬剤学 / ドラッグデリバリーシステム / ナノドラッグ / 遺伝子製剤 / デコイ型遺伝子 / IRF-1 / デコイ型遺伝子製剤 / リポソーム |
Research Abstract |
In this study, I showed that the shield-arms type oligonucleotide was able to down-regulate VEGF expression dependent on TGF-〓 in macrophage and induce anti-tumor effect by enhancement of IRF-1 expression in macrophage residing the tumor environment. It is suggested that this oligonucleotide will become new strategy of anti-angiogenesis by suppression of cancer as shields and activation for macrophages asarms.
|
Report
(3 results)
Research Products
(6 results)
-
-
-
-
-
-
[Patent(Industrial Property Rights)] Method of delivering agent into target cell2011
Inventor(s)
HAGA, Makoto; (JP).FUJIWARA, Naruyoshi; (JP).NISHI, Akihiro; (JP).KUBO, Satoru; (JP).KUSHIBIKI, Takanori; (JP)
Industrial Property Rights Holder
HAGA, Makoto [JP/JP]; (JP) (For US Only).FUJIWARA, Naruyoshi [JP/JP]; (JP) (For US Only).NISHI, Akihiro [JP/JP]; (JP) (For US Only).KUBO, Satoru [JP/JP]; (JP) (For US Only).KUSHIBIKI, Takanori[JP/JP]; (JP) (For US Only)
Filing Date
2011
Related Report
Overseas